Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

NCT03047473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme of Brain

Interventions

BIOLOGICAL: avelumab

Sponsor

Clinique Neuro-Outaouais